ArticleHaematologica2019

Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?

Monika Engelhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.